BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Artificial Intelligence in Healthcare Market Size 2022-2030-Increasing Dependency On Data To Facilitate Better Healthcare Services

  Rising volume of complex data and reduction in hardware costs is projected to drive growth of the artificial intelligence in healthcare market.

  May 24, 2022

   · 

  7 min read
• Cardiovascular Devices Market Trends-2022- Product Launches And Research For Cardiovascular Device Market

  Increasing cardiovascular disease prevalence, product launches, favorable research funding to drive cardiovascular device market growth.

  May 24, 2022

   · 

  7 min read
• DNA and Gene Chip Market Growth, Revenue Share Analysis, Company Profiles, and Forecast To 2028

  High prevalence of cancer, technical knowledge about gene expression and favorable research funding scenario would drive market growth

  May 24, 2022

   · 

  7 min read
• Epigenetics Market Analysis By Opportunities, Size, Share, Growth Factors, Regional And Competitive Landscape Forecast To 2028

  Increasing research activities and funding in the field of epigenetics, rising prevalence of target diseases/disorders, reduced sequencing time, and increasing geriatric population are key factors contributing to high CAGR of epigenetics market during the forecast period.

  May 24, 2022

   · 

  9 min read
• Nanomedicine Market Size 2022-2030-Increasing Adoption Of Nanomedicine In Healthcare Sector

  Extensive adoption of nanomedicine in drug and delivery systems due to rising technological advancement is driving nanomedicine market revenue growth

  May 24, 2022

   · 

  8 min read
• Oligonucleotide Synthesis Market Trends-2022-Increasing Adoption Of Personalized Medicine

  Increasing investments in research and development activities and increasing adoption of synthesized oligonucleotides in molecular diagnostics and therapeutics are key factors fueling global market growth

  May 24, 2022

   · 

  7 min read
• Business

  Shasqi Appoints Steve Abella, M.D., as Chief Medical Officer and Scott Wieland, Ph.D., MBA, as SVP of Clinical Development

  Shasqi, a clinical-stage biotechnology company developing click chemistry-activated oncology therapeutics, announced the additions of Steve Abella, M.D., as Chief Medical Officer and Scott Wieland, Ph.D., MBA, as Senior Vice President of Clinical Development.

  May 24, 2022

   · 

  5 min read
• Evonik sells TAeTTOOz® materials technology for printable rechargeable batteries to InnovationLab

  Evonik is selling the TAeTTOOz® materials technology for printable rechargeable batteries to the InnovationLab GmbH. The InnovationLab specializes in the development of printed and organic electronics and offers individual overall solutions from the first concept draft to the industrial production.

  May 24, 2022

   · 

  3 min read
• Biotech Bay

  Second Genome Presents New Data at Digestive Disease Week (DDW) 2022 Demonstrating that SG-5-00455, a Potential First-in-Class Precision Therapeutic, Improves Epithelial Barrier Function and Promotes Mucosal Healing in Inflammatory Bowel Disease

  Second Genome, presented data demonstrating the Company’s development candidate, SG-5-00455, improves epithelial barrier function and promotes mucosal healing by effectively inhibiting plasminogen activator inhibitor (PAI)-1/2 activity in the intestines.

  May 24, 2022

   · 

  4 min read
• Pharm Country

  Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - May 24, 2022

  Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, announced that, effective May 23, 2022, its independent directors approved equity awards under Helius’ 2021 Inducement Plan, as a material inducement to four individuals entering into employment with the Company.

  May 24, 2022

   · 

  2 min read